WST — WEST PHARMACEUTICAL SERVICES INC

NYSE · Health Care · Health Care Equipment & Supplies · CIK 105770 ·
Last close
$337.46
Market Cap
$23.75B
52W High
$386.00
52W Low
$293.48
ADV30
887,187
Next earnings
2026-10-22
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026 872,300,000 329,200,000 191,900,000 154,000,000 4,076,400,000 435,800,000 1,086,200,000
Mar 2026 844,900,000 296,400,000 181,100,000 138,800,000 4,109,800,000 521,400,000 1,119,400,000
Dec 2025 805,000,000 303,900,000 175,100,000 132,100,000 4,270,000,000 791,300,000 1,094,000,000
Sep 2025 804,600,000 294,300,000 174,500,000 140,000,000 4,105,800,000 628,500,000 1,054,300,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$662,200,000
Investing CF
$-225,300,000
Financing CF
$-496,700,000
CapEx
$-225,300,000
Dividends Paid
$-62,400,000
Buybacks
$-457,100,000
EPS Diluted TTM
$7.81
As of
2026-07-26

Balance + Analyst (yfinance extras)

Retained Earnings
$4,624,100,000
Inventory
$447,400,000
Receivables
$712,000,000
ST Investments
EBIT TTM
$698,100,000
Pretax Income TTM
$693,600,000
Interest Exp TTM
$4,500,000
Analysts
15

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,326,799,872
EBITDA
$912,200,000
Free Cash Flow
$277,937,504
Enterprise Value
$23,629,705,216
Total Cash
$435,800,000
Total Debt
$316,500,000
Shares Out
70,375,762
Trailing EPS
$7.82
Book Value
$42.18
ROE
19.1%
ROA
11.4%
Div Yield
0.26%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 3,074,100,000 636,100,000 493,700,000 4,270,000,000 1,094,000,000 754,800,000
Dec 2024 2,893,200,000 590,900,000 492,700,000 3,643,400,000 961,100,000 653,400,000
Dec 2023 2,949,800,000 707,400,000 593,400,000 3,829,500,000 948,500,000 776,500,000
Dec 2022 2,886,900,000 760,800,000 585,900,000 3,616,800,000 931,900,000 724,000,000

TTM Snapshot

Revenues TTM
$2,887,700,000
NetIncome TTM
$593,500,000
OpCashFlow TTM
$0
Assets (Latest)
$3,643,400,000
Forward EPS
$9.94

Max Pain — expiry 2026-12-18

max pain strike: $280.00 · spot: $337.46 · call oi: 778 · put oi: 686

Peers — same industry

TickerNameMarket CapLastDaily %
RSMDF RESMED INC $24.25B $16.72
RYLPF KONINKLIJKE PHILIPS NV $24.29B $24.85
STE STERIS plc $22.89B $234.83
PHG KONINKLIJKE PHILIPS NV $25.51B $26.10
FSNUY Fresenius SE & Co. KGaA $28.84B $12.80

News headlines (Yahoo Finance, 1h cache)

GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
2026-07-29 15:42 · Yahoo
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
2026-07-29 15:03 · Yahoo
Bio-Techne's Q4 Earnings on Deck: What's in Store for the Stock?
2026-07-29 13:05 · Yahoo
STERIS' Q1 Earnings on Deck: What's in Store for the Stock?
2026-07-28 13:43 · Yahoo
MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access
2026-07-27 13:24 · Yahoo
Here's How IDEXX Laboratories Is Placed Ahead of Q2 Earnings
2026-07-27 13:11 · Yahoo
Beat the Market Like Zacks: Monster Beverage, Carpenter Tech, Usio in Focus
2026-07-27 12:15 · Yahoo
West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan
2026-07-26 05:12 · Yahoo
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
2026-07-24 22:49 · Yahoo
Here's Why You Should Add Cencora Stock to Your Portfolio Now
2026-07-24 15:09 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.